Advertisement
Canada markets open in 2 hours 19 minutes

  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     

  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     

  • DOW

    37,735.11
    -248.13 (-0.65%)
     

  • CAD/USD

    0.7251
    -0.0003 (-0.04%)
     

  • CRUDE OIL

    85.05
    -0.36 (-0.42%)
     

  • Bitcoin CAD

    86,542.51
    -5,137.42 (-5.60%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,387.50
    +4.50 (+0.19%)
     

  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     

  • 10-Yr Bond

    4.6280
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,858.00
    -18.25 (-0.10%)
     

  • VOLATILITY

    19.35
    +0.12 (+0.62%)
     

  • FTSE

    7,851.34
    -114.19 (-1.43%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6817
    -0.0007 (-0.10%)
     
MARKETS LIVE BLOG:

STOCKS SLIP WITH MIDEAST TENSIONS, EARNINGS IN PLAY

Oil pares losses as traders anticipate Israel's response to Iranian attack

Here’s Why The Mayo Clinic Owns 10% of This Unknown Epilepsy Stock with Big Upcoming FDA Catalyst

Baystreet.ca
Updated

- About 1/3 of epilepsy patients fail to respond to drugs, and many of these patients are eligible for potentially curative surgical resection. But most patients won't undergo the extensive diagnostic and surgical process, as it requires invasive access to the brain and long hospital stays, even though this remains one of the most effective treatments - NeuroOne Medical (NMTC) could flip this completely, making the diagnostic process shorter and the intervention easier and quicker for doctors and ... Click here to view full article